151. Bone Morphogenetic Protein-4 (BMP4): A Paracrine Regulator of Human Adrenal C19 Steroid Synthesis.
- Author
-
Rege J, Nishimoto HK, Nishimoto K, Rodgers RJ, Auchus RJ, and Rainey WE
- Subjects
- Adrenal Glands metabolism, Bone Morphogenetic Protein 4 metabolism, Bone Morphogenetic Protein 4 pharmacology, Bone Morphogenetic Protein Receptors, Type I metabolism, Bone Morphogenetic Protein Receptors, Type II metabolism, Cell Line, Cholesterol Side-Chain Cleavage Enzyme drug effects, Cholesterol Side-Chain Cleavage Enzyme genetics, Gene Expression Profiling, Humans, Paracrine Communication genetics, Progesterone Reductase drug effects, Progesterone Reductase genetics, RNA, Messenger drug effects, Reverse Transcriptase Polymerase Chain Reaction, Smad1 Protein metabolism, Smad4 Protein metabolism, Smad5 Protein metabolism, Steroid 17-alpha-Hydroxylase drug effects, Steroid 17-alpha-Hydroxylase genetics, Zona Fasciculata metabolism, Zona Glomerulosa metabolism, Zona Reticularis metabolism, Adrenal Cortex metabolism, Androstenedione biosynthesis, Bone Morphogenetic Protein 4 genetics, Dehydroepiandrosterone biosynthesis, Dehydroepiandrosterone Sulfate metabolism, RNA, Messenger metabolism
- Abstract
Bone morphogenetic proteins (BMPs) comprise one of the largest subgroups in the TGF-β ligand superfamily. We have identified a functional BMP system equipped with the ligand (BMP4), receptors (BMP type II receptor, BMP type IA receptor, also called ALK3) and the signaling proteins, namely the mothers against decapentaplegic homologs 1, 4, and 5 in the human adrenal gland and the human adrenocortical cell line H295R. Microarray, quantitative RT-PCR, and immunohistochemistry confirmed that BMP4 expression was highest in the adrenal zona glomerulosa followed by the zona fasciculata and zona reticularis. Treatment of H295R cells with BMP4 caused phosphorylation of the mothers against decapentaplegic and a profound decrease in synthesis of the C19 steroids dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione. Administration of BMP4 to cultures of H295R cells also caused a profound decrease in the mRNA and protein levels of 17α-hydroxylase/17,20-lyase (CYP17A1 and P450c17, respectively) but no significant effect on the mRNA levels of cholesterol side-chain cleavage cytochrome P450 (CYP11A1) or type 2 3β-hydroxysteroid dehydrogenase (HSD3B2). Furthermore, Noggin (a BMP inhibitor) was able to reverse the negative effects of BMP4 with respect to both CYP17A1 transcription and DHEA secretion in the H295R cell line. Collectively the present data suggest that BMP4 is an autocrine/paracrine negative regulator of C19 steroid synthesis in the human adrenal and works by suppressing P450c17.
- Published
- 2015
- Full Text
- View/download PDF